Amphastar Pharmaceuticals, Inc.
AMPH
$19.54
$0.542.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.43M | 17.35M | 31.03M | 25.29M | 37.96M |
| Total Depreciation and Amortization | 15.99M | 15.77M | 16.24M | 15.21M | 14.66M |
| Total Amortization of Deferred Charges | 866.00K | 885.00K | 842.00K | 762.00K | 724.00K |
| Total Other Non-Cash Items | 34.31M | 6.58M | 6.01M | 10.54M | -15.74M |
| Change in Net Operating Assets | -42.73M | 12.00M | -18.53M | -16.71M | -8.59M |
| Cash from Operations | 32.86M | 52.58M | 35.59M | 35.08M | 29.02M |
| Capital Expenditure | -8.27M | -5.35M | -10.57M | -10.70M | -12.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.30M | -14.27M | 9.94M | 21.18M | -23.27M |
| Cash from Investing | -60.57M | -19.62M | -625.00K | 10.48M | -35.68M |
| Total Debt Issued | 273.00K | 172.00K | 4.13M | 1.64M | 4.87M |
| Total Debt Repaid | -104.00K | -44.00K | -37.00K | -38.00K | -115.00K |
| Issuance of Common Stock | 1.98M | 379.00K | 494.00K | -- | -- |
| Repurchase of Common Stock | -20.52M | -4.85M | -34.54M | -15.69M | -38.62M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.00K | -4.00K | -253.00K | -422.00K | 22.00K |
| Cash from Financing | -18.37M | -4.35M | -30.20M | -14.50M | -33.84M |
| Foreign Exchange rate Adjustments | -9.00K | -41.00K | 142.00K | 118.00K | -11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.09M | 28.58M | 4.91M | 31.17M | -40.51M |